Chikungunya Vaccine: Effectiveness and Safety Study

We are evaluating how well the chikungunya vaccine works in preventing severe disease and hospitalizations in at-risk populations. This study aims to understand the vaccine's real-life impact on health outcomes.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Dengue Tetravalent Vaccine (Live, Attenuated) Takeda
Dengue Tetravalent Vaccine (Live, Attenuated) Takeda is a vaccine that helps prevent dengue fever caused by all four types of dengue virus.
Ixchiq

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Attenuated
Chikungunya Virus
Chikungunya virus causes sudden fever and intense joint pain transmitted by mosquitoes.
Dengue Virus

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Qdenga

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Cabinet du Dr Blanc
General Medical Practice
Limassol, France
Cabinet du Dr. RONCO
General Medical Practice
Limassol, France
Centre Hospitalier Universitaire De La Reunion
Infectious Diseases and Tropical Medicine North
Limassol, France

Sponsor: Centre Hospitalier Universitaire De La Reunion
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.